Department of Anesthesiology, Columbia University Medical Center, New York Presbyterian Hospital, New York, NY.
Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Mass.
J Thorac Cardiovasc Surg. 2022 Feb;163(2):676-682.e1. doi: 10.1016/j.jtcvs.2020.03.072. Epub 2020 Apr 11.
Publicly reported postoperative 30-day mortality rates are commonly used to compare hospital quality after coronary artery bypass grafting. We sought to determine whether 90-day mortality rates, which are not publicly reported but better capture postdischarge mortality, are a better determinant of hospital performance.
We performed a retrospective cohort analysis of 30- versus 90-day risk-standardized mortality rates at adult cardiac surgical centers in New York State from 2008 to 2014. Hospitals were classified as good or poor performing outliers at each time point based on the bounds of the 95% confidence interval around each hospital's predicted risk-standardized mortality rates determined via hierarchical models. The primary outcome was change in institutional performance via outlier classification from 30 to 90 days.
During the study period, 72,398 adults underwent a coronary artery bypass grafting procedure at 1 of 42 institutions. The risk-standardized mortality rates increased from 30 to 90 days at all institutions, with a median 30-day risk-standardized mortality rate of 2.16% (interquartile range, 0.69%) and median 90-day risk-standardized mortality rate of 3.69% (interquartile range, 1.00%). In using a 90-day instead of a 30-day metric, 3 hospitals changed outlier status. One hospital improved to a good from as expected performer, and 2 worsened to as expected from good performers.
In a cohort of patients who underwent coronary artery bypass grafting surgery from 2008 to 2014 in New York State, use of a 90-day mortality metric resulted in a change in hospital quality assessment for a minority of hospitals. The use of 90-day mortality may not provide additional value when evaluating institutional performance for this population.
公开报告的术后 30 天死亡率常用于比较冠状动脉旁路移植术后的医院质量。我们旨在确定 90 天死亡率(未公开报告,但更好地反映出院后死亡率)是否是医院表现的更好决定因素。
我们对 2008 年至 2014 年纽约州成人心脏外科中心的 30 天与 90 天风险标准化死亡率进行了回顾性队列分析。根据通过分层模型确定的每个医院预测风险标准化死亡率的 95%置信区间的边界,在每个时间点将医院分类为表现良好或表现较差的异常值。主要结局是通过异常值分类从 30 天到 90 天的机构绩效变化。
在研究期间,42 家机构中的 72398 名成年人接受了冠状动脉旁路移植术。所有医院的风险标准化死亡率从 30 天增加到 90 天,中位数 30 天风险标准化死亡率为 2.16%(四分位距,0.69%),中位数 90 天风险标准化死亡率为 3.69%(四分位距,1.00%)。使用 90 天而不是 30 天的指标,有 3 家医院的异常值状态发生变化。一家医院从表现不佳的预期演变为表现良好的预期,另外两家医院从表现良好的预期演变为表现不佳的预期。
在 2008 年至 2014 年期间在纽约州接受冠状动脉旁路移植术的患者队列中,使用 90 天死亡率指标导致少数医院的医院质量评估发生变化。在评估该人群的机构绩效时,使用 90 天死亡率可能不会提供额外价值。